Laurion Capital Management’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Laurion Capital Management’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-16,666	Closed	-$14K	–	570
2022 Q3	$14K	Hold	16,666	–	–	﹤0.01%	464
2022 Q2	$1K	Hold	16,666	–	–	﹤0.01%	455
2022 Q1	$4K	Hold	16,666	–	–	﹤0.01%	516
2021 Q4	$10K	Hold	16,666	–	–	﹤0.01%	526
2021 Q3	$11K	Hold	16,666	–	–	﹤0.01%	659
2021 Q2	$18K	Buy	+16,666	New	+$16.6K	﹤0.01%	674

Laurion Capital Management's FLACW Position: Q4 2022 in Review

Laurion Capital Management sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 16,666 shares — an estimated $14K sold.

Laurion Capital Management first reported a position in FLACW in Q2 2021 and held it in 6 quarters. The position peaked at $18K in Q2 2021. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Laurion Capital Management reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Laurion Capital Management sold 16,666 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $14K.
Laurion Capital Management first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q2 2021 and held it in 6 quarters.
Laurion Capital Management's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $18K in Q2 2021.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Laurion Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.